Kahira Pharmaceuticals

Last Updated:
  • 115.98 EGP
  • 0.06
  • 0.05%
القاهرة للادوية والصناعات الكيماوية
القاهرة للادوية
Symbol : CPCI
ISIN : EGS38391C016
Day Range : -
Turnover Ratio : 0.09
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Latest Announcements
2024-12-23 06:53:00.0العنوان : القاهرة للادوية والصناعات الكيماوية (CPCI.CA) اعلان تذكيرياسم الشركة : القاهرة للادوية والصناعات الكيماويةكود الترقيم الدولي : EGS
2024-12-19 07:32:00.0العنوان : القاهرة للادوية والصناعات الكيماوية (CPCI.CA) قرار لجنة القيد بجلستها المنعقدة بتاريخ 18/12/2024اسم الشركة : القاهرة للادوية والصناعات
2024-12-11 07:36:00.0Cairo Pharmaceuticals (CPCI.CA) Declares Cash Dividends
2024-12-04 12:57:00.0العنوان : القاهرة للادوية والصناعات الكيماوية (CPCI.CA) قرار لجنة القيد بجلستها المنعقدة بتاريخ 04/12/2024اسم الشركة : القاهرة للادوية والصناعات
2024-12-01 07:37:00.0Cairo Pharmaceuticals (CPCI.CA)- AGM Minutes (before Certification)

Kahira Pharmaceuticals Stock Overview

View Company Profile

Stock Summary

Last Price (EGP) 115.98
Prev. Close 115.920
Day Range 114.63 - 116.80
52WK range
Turnover (M EGP) 0.21
Volume (M) 0.00
Number of Trades 18
Market Cap (M EGP) 1,730.60
Change in Market Cap (M EGP)
VWAP (EGP) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M EGP)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
23-Dec-2024 Record date for dividend eligibility
26-Dec-2024 Distribution of cash dividends

Cairo – Mubasher: Kahira Pharmaceuticals posted a 22.47% year-on-year (YoY) increase in profits after tax during the first half (H1) of fiscal year...

Cairo – Mubasher: The Egyptian Exchange (EGX) has announced a block trading deal worth EGP 9.24 million on the shares of Kahira...

Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman.The...

Cairo – Mubasher: Kahira Pharmaceuticals achieved net profits of EGP 102.9 million in the first nine months of fiscal year (FY) 2020/2021, up by...

Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the planned budget for fiscal year 2021/2022.The company aims to achieve...